AWC
ABBV icon

Adamsbrown Wealth Consultants’s AbbVie ABBV Stock Holding History

Adamsbrown Wealth Consultants’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$486K Buy
1,930
+4
+0.2% +$861 0.09% 84
2026
Q1 		$419K Buy
1,926
+117
+6% +$26K 0.11% 82
2025
Q4 		$413K Buy
1,809
+4
+0.2% +$911 0.12% 77
2025
Q3 		$418K Sell
1,805
-22
-1% -$4.48K 0.12% 71
2025
Q2 		$339K Buy
1,827
+25
+1% +$4.65K 0.1% 72
2025
Q1 		$378K Buy
1,802
+280
+18% +$54.4K 0.12% 63
2024
Q4 		$270K Buy
1,522
+8
+0.5% +$1.47K 0.09% 83
2024
Q3 		$299K Buy
1,514
+41
+3% +$7.65K 0.1% 70
2024
Q2 		$253K Buy
1,473
+17
+1% +$2.82K 0.1% 74
2024
Q1 		$265K Sell
1,456
-7
-0.5% -$1.21K 0.11% 67
2023
Q4 		$227K Buy
1,463
+51
+4% +$7.43K 0.1% 73
2023
Q3 		$210K Buy
+1,412
New +$207K 0.1% 74

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Adamsbrown Wealth Consultants's ABBV Position: Q2 2026 in Review

Adamsbrown Wealth Consultants increased its AbbVie (ABBV) stake by 0.21% in Q2 2026, buying an estimated $861 and bringing the position to 1,930 shares worth $486K. The position accounts for 0.09% of the portfolio, ranked #84.

Adamsbrown Wealth Consultants first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Adamsbrown Wealth Consultants held 1,930 shares of AbbVie worth $486K as of Q2 2026.
  • Adamsbrown Wealth Consultants bought 4 AbbVie shares in Q2 2026, an estimated $861.
  • AbbVie made up 0.09% of Adamsbrown Wealth Consultants's portfolio in Q2 2026, its #84 holding.
  • Adamsbrown Wealth Consultants first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Adamsbrown Wealth Consultants's 13F filing for Q2 2026, filed 9 Jul 2026.